Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017

Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017

The decline in the proportion of pneumococcal conjugate vaccine (PCV)–covered serotypes among adult invasive pneumococcal disease (IPD) patients might change the overall effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) because its effectiveness differs according to serotyp...

Full description

Bibliographic Details
Main Authors: Reiko Shimbashi, Motoi Suzuki, Bin Chang, Hiroshi Watanabe, Yoshinari Tanabe, Koji Kuronuma, Kengo Oshima, Takaya Maruyama, Hiroaki Takeda, Kei Kasahara, Jiro Fujita, Junichiro Nishi, Tetsuya Kubota, Keiko Tanaka-Taya, Tamano Matsui, Tomimasa Sunagawa, Kazunori Oishi
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2020-10-01
Series:Emerging Infectious Diseases
Subjects:
PPSV23
23-valent pneumococcal polysaccharide vaccine
IPD
invasive pneumococcal disease
vaccine effectiveness
indirect cohort method
Online Access:https://wwwnc.cdc.gov/eid/article/26/10/19-1531_article

Internet

https://wwwnc.cdc.gov/eid/article/26/10/19-1531_article

Similar Items